Brief: Regencell Bioscience Ltd Enters Joint Venture For COVID-19 Treatment
Sept 2 (Reuters) - Regencell Bioscience Holdings Ltd
RGC.O :
* REGENCELL BIOSCIENCE HOLDINGS LIMITED ESTABLISHES A JOINT
VENTURE TO OFFER COVID TREATMENT
Source text for Eikon: ID:nBw1SH2Cpa
Further company coverage: RGC.O
((Reuters.Briefs@thomsonreuters.com;))